Abstract

High dose therapy and allogeneic hematopoietic stem cell transplantation (HCT) began at Seattle's Fred Hutchinson Cancer Research Center in the 1960s, led by Nobel Prize–winning E. Donnall Thomas, MD, and represented one of the first curative treatments for relapsed leukemia.